PharmaGraphX

Log in Get Started

Nebivolol

Byvalson, Bystolic

Beta • adrenergic blocker

Standard

Half-life

12-19 hours (extensive metabolizers); ~40 hours (poor metabolizers)

Protein Binding

98%

Metabolized By

N/A

External

Drugs.com

Mechanism of action

Selectively blocks beta-1 receptors; also stimulates endothelial nitric oxide release

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·Liver Cirrhosis
·Arterial Hypertension
·Heart Failure
·Atrial Fibrillation
·Rate Control

Interactions

No curated interaction pairs are recorded for Nebivolol. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Headache
Fatigue
Dizziness
Diarrhea

Food, alcohol & herbal

Alcohol · moderate

Additive hypotension

Pharmacokinetics

Half-life: 12-19 hours (extensive metabolizers); ~40 hours (poor metabolizers)
Protein binding: 98%
Metabolised by: CYP2D6

Pregnancy & lactation

Not recorded for Nebivolol. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement